Solid pharmaceutical dosage form suitable for use as drinking water medication

US10335371B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10335371-B2
Application numberUS-201615551636-A
CountryUS
Kind codeB2
Filing dateFeb 17, 2016
Priority dateFeb 17, 2015
Publication dateJul 2, 2019
Grant dateJul 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to solid pharmaceutical dosage forms suitable for use as drinking water medication. More in particular, the present invention provides solid pharmaceutical dosage forms comprising a pharmaceutically active agent, a non-ionic surfactant having an Hydrophilic Lipophilic Balance (HLB) of at least 8, and a maltodextrin. The present invention also provides the use of such pharmaceutical dosage forms in veterinary medicine, more in particular as drinking water medication; as well as methods for preparing such pharmaceutical dosage forms.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for the preparation of a spray-dried solid pharmaceutical multiparticulate dosage form, the method comprising: preparing a suspension comprising a pharmaceutical non-solubilized active ingredient, a non-ionic surfactant having an Hydrophilic Lipophilic Balance (HLB) of at least 8 and water; milling the suspension; adding a maltodextrin to the milled suspension; and spray-drying the milled suspension. 2. The method according to claim 1 , wherein: the non-ionic surfactant has an HLB of 8 to 20; and the pharmaceutical non-solubilized active ingredient is selected from the group consisting of antibiotics, anticoccidials, and non-steroidal anti-inflammatory drugs. 3. The method according to claim 1 , wherein the pharmaceutical non-solubilized active ingredient is a poorly water-soluble active agent. 4. The method according to claim 1 , wherein the pharmaceutical non-solubilized active ingredient is selected from the group consisting of pyrimidine antibacterial chemotherapeutics, macrocylic lactones, anticoccidials, and non-steroidal anti-inflammatory drugs. 5. The method according to claim 1 , wherein the non-ionic surfactant is a polysorbate selected from the group consisting of polysorbate 20, polysorbate 40, polysorbate 60, and polysorbate 80. 6. The method according to claim 1 , wherein the maltodextrin is selected from the group consisting of maltodextrin with a Dextrose Equivalent (DE) of 9, maltodextrin with a DE of 14, and maltodextrin with a DE of 18.

Assignees

Inventors

Classifications

  • Animal feeding-stuffs · CPC title

  • containing oxygen or sulfur as hetero atom · CPC title

  • Sugars; Polysaccharides · CPC title

  • Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006) · CPC title

  • for poultry · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10335371B2 cover?
The present invention relates to solid pharmaceutical dosage forms suitable for use as drinking water medication. More in particular, the present invention provides solid pharmaceutical dosage forms comprising a pharmaceutically active agent, a non-ionic surfactant having an Hydrophilic Lipophilic Balance (HLB) of at least 8, and a maltodextrin. The present invention also provides the use of su…
Who is the assignee on this patent?
Univ Gent, Orotech Nv
What technology area does this patent fall under?
Primary CPC classification A61K9/1652. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).